Zoledronic acid is superior to tenofovir disoproxil fumarate-switching for low bone mineral density in adults with HIV

Hoy Jennifer F.; Richardson Robyn; Ebeling Peter R.; Rojas Jhon; Pocock Nicholas; Kerr Stephen J.; Martinez Esteban; Carr Andrew

首页> 外文期刊>AIDS >Zoledronic acid is superior to tenofovir disoproxil fumarate-switching for low bone mineral density in adults with HIV

【24h】

Zoledronic acid is superior to tenofovir disoproxil fumarate-switching for low bone mineral density in adults with HIV

机译：唑醇酸优于替诺福韦毒性富马酸薄物切换，用于艾滋病毒的成人低骨矿物密度

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objective: To compare the effects of switching tenofovir disoproxil fumarate (TDF) or treatment with an intravenous bisphosphonate on bone mineral density (BMD) in HIV-positive adults with low bone mass.

机译：目的：比较切换替诺福韦富马酸氟盐（TDF）的影响或用静脉染色的骨质矿物密度（BMD）在低骨量的骨矿物密度（BMD）上的影响。

著录项

来源
《AIDS》 |2018年第14期|共9页
作者
Hoy Jennifer F.; Richardson Robyn; Ebeling Peter R.; Rojas Jhon; Pocock Nicholas; Kerr Stephen J.; Martinez Esteban; Carr Andrew;
展开▼
作者单位

Alfred Hosp Melbourne Vic Australia;

St Vincents Hosp Sydney NSW Australia;

Monash Univ 85 Commercial Rd Melbourne Vic 3004 Australia;

Univ Barcelona Hosp Clin Barcelona Spain;

St Vincents Hosp Sydney NSW Australia;

St Vincents Hosp Sydney NSW Australia;

Univ Barcelona Hosp Clin Barcelona Spain;

St Vincents Hosp Sydney NSW Australia;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类传染病;
关键词
bone mineral density; HIV; osteoporosis; tenofovir; zoledronic acid;

机译：骨密度;艾滋病毒;骨质疏松症;替诺维尔;唑醇;

相似文献

外文文献
中文文献
专利

1. Zoledronic acid is superior to tenofovir disoproxil fumarate-switching for low bone mineral density in adults with HIV [J] . Hoy Jennifer F., Richardson Robyn, Ebeling Peter R., AIDS . 2018,第14期

机译：唑醇酸优于替诺福韦毒性富马酸薄物切换，用于艾滋病毒的成人低骨矿物密度
2. Impact of Switching From Zidovudine to Tenofovir Disoproxil Fumarate on Bone Mineral Density and Markers of Bone Metabolism in Virologically Suppressed HIV-1 Infected Patients; A Substudy of the PREPARE Study [J] . Aoife G. Cotter, Saskia M. E. Vrouenraets, Jennifer J. Brady, The journal of clinical endocrinology and metabolism . 2013,第4期

机译：从齐多夫定改为替诺福韦富马酸替诺福韦酯对病毒学抑制的HIV-1感染患者骨矿物质密度和骨代谢指标的影响; PREPARE研究的子研究
3. Tenofovir disoproxil fumarate and bone mineral density: a 60-month longitudinal study in a cohort of HIV-infected youths. [J] . Vigano A, Zuccotti GV, Puzzovio M, Antiviral therapy . 2010,第7期

机译：替诺福韦富马酸替索罗非酯和骨矿物质密度：一项针对60个月的纵向研究，研究对象是一群感染HIV的青年。
4. Identification of a Novel Metabolite for The HIV treatment Tenofovir Disoproxil with LC-MS/MS [C] . Leanne C. Nye, Myra McClure, Steve Kaye, International Mass Spectrometry Conference . 2014

机译：用LC-MS / MS鉴定艾滋病毒治疗Tenofovir Disoproxil的新型代谢物
5. Enhanced lumbar spine bone mineral content and bone mineral density in SGA piglets fed arachidonic acid and docosahexaenoic acid are modulated by birth weight. [D] . Kohut, June R. 2005

机译：SGA仔猪饲喂花生四烯酸和二十二碳六烯酸的腰椎骨矿物质含量和骨矿物质密度的增加受到出生体重的调节。
6. Vitamin D3 Supplementation Increases Spine Bone Mineral Density in Adolescents and Young Adults With Human Immunodeficiency Virus Infection Being Treated With Tenofovir Disoproxil Fumarate: A Randomized Placebo-Controlled Trial [O] . Peter L Havens, Charles B Stephensen, Marta D Van Loan, -1

机译：补充维生素D3可增加替诺福韦酯富马酸盐治疗的人类免疫缺陷病毒感染的青少年和年轻人的脊柱骨矿物质密度：一项随机安慰剂对照的试验
7. Impact of Switching From Zidovudine to Tenofovir Disoproxil Fumarate on Bone Mineral Density and Markers of Bone Metabolism in Virologically Suppressed HIV-1 Infected Patients; A Substudy of the PREPARE Study [O] . Cotter, Aoife G., Vrouenraets, Saskia M. E., Brady, Jennifer J., 2013

机译：从齐多夫定改为替诺福韦富马酸替诺福韦酯对病毒学抑制的HIV-1感染患者骨矿物质密度和骨代谢指标的影响； PREPARE研究的子研究

Zoledronic acid is superior to tenofovir disoproxil fumarate-switching for low bone mineral density in adults with HIV

摘要

著录项

相似文献

相关主题

期刊订阅